Skip Content
You are currently on the new version of our website. Access the old version .

Vaccines, Volume 11, Issue 5

2023 May - 132 articles

Cover Story: Tropical diseases caused by filarial nematodes such as lymphatic filariasis (elephantiasis) and onchocerciasis (river blindness) affect hundreds of millions of people worldwide. Despite decades of research, no vaccines against any filaria or helminths in general are available for use in human patients as of 2023. In this study by Scheunemann et al., the use of nucleic acid receptor agonists as potential vaccine adjuvants for filarial infections was evaluated in the Litomosoides sigmodontis rodent model. The authors reported that the use of poly(I:C), a TLR-3, MDA5, RIG-I ligand, and 3pRNA, a RIG-I ligand, improved the protective efficacy in comparison to the vaccination with irradiated L3 larvae alone and elicited stronger parasite-specific immune responses, highlighting the use of nucleic acid receptor agonists as promising vaccine strategies for filarial and other helminth infections. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (132)

  • Review
  • Open Access
23 Citations
7,236 Views
23 Pages

Vaccines against Tuberculosis: Where Are We Now?

  • Shruti Srivastava,
  • Sajal Dey and
  • Sangita Mukhopadhyay

22 May 2023

Tuberculosis (TB) is among the top 10 leading causes of death in low-income countries. Statistically, TB kills more than 30,000 people each week and leads to more deaths than any other infectious disease, such as acquired immunodeficiency syndrome (A...

  • Article
  • Open Access
6 Citations
2,947 Views
16 Pages

A Third Dose of SARS-CoV-2 mRNA Vaccine Improves Immune Response in Chronic Kidney Disease Patients

  • Maria Cecilia Poli,
  • Cecilia Vial,
  • Emma Rey-Jurado,
  • Natalia González,
  • Lina Jimena Cortés,
  • Juan Hormazabal,
  • Carolina Ramírez-Riffo,
  • Javiera de la Cruz and
  • Camilo Ulloa

22 May 2023

Chronic kidney disease (CKD) patients have an increased risk of morbidity and mortality following SARS-CoV-2 infection. Vaccination in these patients is prioritized, and monitoring of the immune response is paramount to define further vaccination str...

  • Systematic Review
  • Open Access
21 Citations
4,696 Views
24 Pages

The Impact of Vaccination on COVID-19 Burden of Disease in the Adult and Elderly Population: A Systematic Review of Italian Evidence

  • Giovanna Elisa Calabrò,
  • Ciro Pappalardo,
  • Floriana D’Ambrosio,
  • Michele Vece,
  • Chiara Lupi,
  • Alberto Lontano,
  • Mattia Di Russo,
  • Roberto Ricciardi and
  • Chiara de Waure

22 May 2023

COVID-19 is a major global health threat, with millions of confirmed cases and deaths worldwide. Containment and mitigation strategies, including vaccination, have been implemented to reduce transmission and protect the population. We conducted two s...

  • Article
  • Open Access
18 Citations
6,039 Views
14 Pages

COVID-19 Vaccination in the WHO African Region: Progress Made in 2022 and Factors Associated

  • Franck Mboussou,
  • Bridget Farham,
  • Sheillah Nsasiirwe,
  • Ajiri Atagbaza,
  • Daniel Oyaole,
  • Phionah Lynn Atuhebwe,
  • Victor Alegana,
  • Fred Osei-sarpong,
  • Ado Bwaka and
  • Benido Impouma
  • + 5 authors

22 May 2023

This study summarizes progress made in rolling out COVID-19 vaccinations in the African region in 2022, and analyzes factors associated with vaccination coverage. Data on vaccine uptake reported to the World Health Organization (WHO) Regional Office...

  • Article
  • Open Access
3 Citations
3,043 Views
11 Pages

22 May 2023

China is relaxing COVID-19 measures from the “dynamic zero tolerance” (DZT) level. The “flatten-the-curve” (FTC) strategy, which decreases and maintains the low rate of infection to avoid overwhelming the healthcare system by...

  • Article
  • Open Access
13 Citations
3,391 Views
15 Pages

Perceptions and Intention to Get Vaccinated against Mpox among the LGBTIQ+ Community during the 2022 Outbreak: A Cross-Sectional Study in Peru

  • Julieta M. Araoz-Salinas,
  • Brando Ortiz-Saavedra,
  • Linda Ponce-Rosas,
  • David R. Soriano-Moreno,
  • Anderson N. Soriano-Moreno,
  • Jorge Alave and
  • Jose A. Gonzales-Zamora

21 May 2023

Vaccination against mpox can control the outbreak by targeting high-risk groups such as the LGBTIQ+ community. The aim of the study was to evaluate the perceptions and intentions to get vaccinated against mpox among the LGBTIQ+ community in Peru. We...

  • Article
  • Open Access
5 Citations
2,950 Views
13 Pages

21 May 2023

Understanding the immunological mechanisms of protection and the viral proteins involved in the induction of a protective immune response to the African swine fever virus (ASFV) is still limited. In the last years, the CD2v protein (gp110-140) of the...

  • Article
  • Open Access
10 Citations
4,164 Views
24 Pages

Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models

  • María M. Lorenzo,
  • Alejandro Marín-López,
  • Kevin Chiem,
  • Luis Jimenez-Cabello,
  • Irfan Ullah,
  • Sergio Utrilla-Trigo,
  • Eva Calvo-Pinilla,
  • Gema Lorenzo,
  • Sandra Moreno and
  • Rafael Blasco
  • + 12 authors

21 May 2023

The COVID-19 pandemic has underscored the importance of swift responses and the necessity of dependable technologies for vaccine development. Our team previously developed a fast cloning system for the modified vaccinia virus Ankara (MVA) vaccine pla...

  • Article
  • Open Access
7 Citations
3,385 Views
16 Pages

Bovine Herpesvirus-4 Based Vaccine Provides Protective Immunity against Streptococcus suis Disease in a Rabbit Model

  • Nihua Dong,
  • Hester Nichols,
  • Qing Sun,
  • Xiaojun Chen,
  • Jiayang Zheng,
  • Zhixin Guan,
  • Hailong Zhang,
  • Andrew Davison,
  • Yvonne Wezel and
  • Jianchao Wei
  • + 10 authors

20 May 2023

Streptococcus suis (S. suis) is a bacterial pathogen of pigs that has a major animal health and economic impact on the pig industry. Bovine herpesvirus-4 (BoHV-4) is a new virus-based vaccine vector that has been used for the immunogenic delivery of...

  • Article
  • Open Access
9 Citations
6,246 Views
13 Pages

A Booster with a Genotype-Matched Inactivated Newcastle Disease Virus (NDV) Vaccine Candidate Provides Better Protection against a Virulent Genotype XIII.2 Virus

  • Ismail Hossain,
  • Jannatul Ferdous Subarna,
  • Congriev Kumar Kabiraj,
  • Jahan Ara Begum,
  • Rokshana Parvin,
  • Mathias Martins,
  • Diego G. Diel,
  • Emdadul Haque Chowdhury,
  • Mohammad Rafiqul Islam and
  • Mohammed Nooruzzaman

20 May 2023

Newcastle disease (ND) is endemic in Bangladesh. Locally produced or imported live Newcastle disease virus (NDV) vaccines based on lentogenic virus strains, locally produced live vaccines of the mesogenic Mukteswar strain, as well as imported inactiv...

  • Article
  • Open Access
11 Citations
5,002 Views
12 Pages

20 May 2023

Previous studies have shown that the herpes zoster subunit vaccine Shingrix™ performs well in clinical trials. However, the key ingredient in its adjuvant, QS21, is extracted from rare plants in South America, so vaccine production is limited....

  • Article
  • Open Access
3 Citations
2,751 Views
12 Pages

20 May 2023

Developing variant vaccines or multivalent vaccines is a feasible way to address the epidemic as the SARS-CoV-2 variants of concern (VOCs) posed an increased risk to global public health. The spike protein of the SARS-CoV-2 virus was usually used as...

  • Article
  • Open Access
8 Citations
3,035 Views
15 Pages

Adaptation and Validation of a French Version of the Vaccination Attitudes Examination (VAX) Scale

  • Margot Eisenblaetter,
  • Clarisse Madiouni,
  • Yasmine Laraki,
  • Delphine Capdevielle and
  • Stéphane Raffard

19 May 2023

Over the past decades, vaccination has proven to be largely beneficial to global health. Despite vaccine efficacy, the French population has been recently affected by more anti-vaccination attitudes and vaccine refusal, and it is therefore necessary...

  • Article
  • Open Access
2,772 Views
14 Pages

No Difference in the Prevalence of HIV-1 gag Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana

  • Baitshepi Mokaleng,
  • Wonderful Tatenda Choga,
  • Ontlametse Thato Bareng,
  • Dorcas Maruapula,
  • Doreen Ditshwanelo,
  • Nametso Kelentse,
  • Patrick Mokgethi,
  • Natasha Onalenna Moraka,
  • Modisa Sekhamo Motswaledi and
  • Simani Gaseitsiwe
  • + 4 authors

19 May 2023

HIV is known to accumulate escape mutations in the gag gene in response to the immune response from cytotoxic T lymphocytes (CTLs). These mutations can occur within an individual as well as at a population level. The population of Botswana exhibits a...

  • Article
  • Open Access
22 Citations
4,180 Views
15 Pages

A First-in-Human Trial to Evaluate the Safety and Immunogenicity of a G Protein-Based Recombinant Respiratory Syncytial Virus Vaccine in Healthy Adults 18–45 Years of Age

  • Xin Cheng,
  • Gan Zhao,
  • Aihua Dong,
  • Zhonghuai He,
  • Jiarong Wang,
  • Brian Jiang,
  • Bo Wang,
  • Miaomiao Wang,
  • Xuefen Huai and
  • Bin Wang
  • + 3 authors

Background: With the enormous morbidity and mortality caused by respiratory syncytial virus (RSV) infections among infants and the elderly, vaccines against RSV infections are in large market demand. Methods: We conducted a first-in-human (FIH), rand...

  • Article
  • Open Access
15 Citations
4,472 Views
19 Pages

Assessment of Safety and Prophylactic Efficacy of the EpiVacCorona Peptide Vaccine for COVID-19 Prevention (Phase III)

  • Alexander B. Ryzhikov,
  • Evgeny A. Ryzhikov,
  • Marina P. Bogryantseva,
  • Svetlana V. Usova,
  • Elena A. Nechaeva,
  • Elena D. Danilenko,
  • Stepan A. Pyankov,
  • Andrey S. Gudymo,
  • Anastasiya A. Moiseeva and
  • Rinat A. Maksyutov
  • + 17 authors

The State Research Center of Virology and Biotechnology “VECTOR” of the Federal Service for the Oversight of Consumer Protection and Welfare (Rospotrebnadzor) has developed the peptide-based EpiVacCorona vaccine, which is the first synthe...

  • Article
  • Open Access
15 Citations
3,637 Views
14 Pages

No research has been conducted to explore the variables associated with healthcare providers’ (HCPs) knowledge and attitudes toward the human papillomavirus vaccine (HPV) since the vaccine was approved for free use in some Chinese cities. In Sh...

  • Systematic Review
  • Open Access
19 Citations
4,232 Views
12 Pages

Objective: The objective of this study was to appraise the interrelation between overweight/obesity and the safety and efficacy of COVID-19 vaccination by synthesizing the currently available evidence. Methods: A systematic review of published studie...

  • Article
  • Open Access
2 Citations
6,317 Views
12 Pages

Evaluation of IL-35, as a Possible Biomarker for Follow-Up after Therapy, in Chronic Human Schistosoma Infection

  • Nadia Marascio,
  • Maria Teresa Loria,
  • Grazia Pavia,
  • Cinzia Peronace,
  • Neill James Adams,
  • Morena Campolo,
  • Francesca Divenuto,
  • Angelo Giuseppe Lamberti,
  • Aida Giancotti and
  • Giovanni Matera
  • + 7 authors

The host response to helminth infections is characterized by systemic and tissue-related immune responses that play a crucial role in pathological diseases. Recently, experimental studies have highlighted the role of regulatory T (Tregs) and B (Bregs...

  • Article
  • Open Access
8 Citations
2,660 Views
15 Pages

Vaccination against seasonal flu is crucial to prevention of illness in modern societies. The level of influenza vaccination in Poland is low and, for many years, has hovered around a few percent of the general population. For this reason, it is cruc...

  • Review
  • Open Access
8 Citations
4,728 Views
18 Pages

Emerging, re-emerging and zoonotic viral pathogens represent a serious threat to human health, resulting in morbidity, mortality and potentially economic instability at a global scale. Certainly, the recent emergence of the novel SARS-CoV-2 virus (an...

  • Article
  • Open Access
9 Citations
2,626 Views
13 Pages

Norovirus infection is the leading cause of foodborne gastroenteritis worldwide, causing more than 200,000 deaths each year. As a result of a lack of reproducible and robust in vitro culture systems and suitable animal models for human norovirus (HuN...

  • Review
  • Open Access
76 Citations
250,552 Views
22 Pages

IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein

  • Vladimir N. Uversky,
  • Elrashdy M. Redwan,
  • William Makis and
  • Alberto Rubio-Casillas

Less than a year after the global emergence of the coronavirus SARS-CoV-2, a novel vaccine platform based on mRNA technology was introduced to the market. Globally, around 13.38 billion COVID-19 vaccine doses of diverse platforms have been administer...

  • Article
  • Open Access
10 Citations
6,066 Views
13 Pages

Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium

  • Maarten J. Postma,
  • Chih-Yuan Cheng,
  • Nasuh C. Buyukkaramikli,
  • Luis Hernandez Pastor,
  • Ine Vandersmissen,
  • Thierry Van Effelterre,
  • Peter Openshaw and
  • Steven Simoens

Respiratory syncytial virus (RSV) is a leading cause of acute respiratory infection (ARI) in older adults. This study used a static, cohort-based decision-tree model to estimate the public health and economic impact of vaccination against RSV in Belg...

  • Article
  • Open Access
7 Citations
3,649 Views
11 Pages

BNT162b2 COVID-19 Vaccines in Children, Adolescents and Young Adults with Cancer—A 1-Year Follow-Up

  • Caroline Donze,
  • Victoria Min,
  • Laetitia Ninove,
  • Xavier de Lamballerie,
  • Gabriel Revon Rivière,
  • Arnauld Verschuur,
  • Paul Saultier and
  • Nicolas André

(1) Background: Children and young adults with cancer are poorly represented in COVID-19 vaccination studies, and long-term protection conferred by vaccination is not known. (2) Objectives: 1. To determine the adverse effects associated with BNT162B2...

  • Article
  • Open Access
1 Citations
9,688 Views
19 Pages

Vaccination rates against SARS-CoV-2 in children aged five to eleven years remain low in many countries. The current benefit of vaccination in this age group has been questioned given that the large majority of children have now experienced at least...

  • Article
  • Open Access
5 Citations
2,605 Views
14 Pages

Future COVID-19 Booster Vaccine Refusal in Healthcare Workers after a Massive Breakthrough Infection Wave, a Nationwide Survey-Based Study

  • Fuying Gu,
  • Huiying Lin,
  • Zhenqiang Chen,
  • Gareth Ambler,
  • Xinyan Chen,
  • Xiaoling Chen,
  • Pincang Xia,
  • Nan Liu and
  • Houwei Du

Background: An unprecedented coronavirus disease 2019 (COVID-19) wave occurred in China between December 2022 and January 2023, challenging the efficacy of the primary series of COVID-19 vaccines. The attitudes toward future COVID-19 booster vaccines...

  • Article
  • Open Access
13 Citations
4,277 Views
14 Pages

During the coronavirus disease 2019 (COVID-19) pandemic, global vaccination efforts declined due to the burden on health systems and community resistance to epidemic control measures. Influenza and pneumococcal vaccines have been recommended for vuln...

  • Article
  • Open Access
15 Citations
4,971 Views
13 Pages

Real-World Effectiveness of Four Types of COVID-19 Vaccines

  • Derar H. Abdel-Qader,
  • Hasan Abdel-Qader,
  • Jennifer Silverthorne,
  • Chuenjid Kongkaew,
  • Ahmad Z. Al Meslamani,
  • Wail Hayajneh,
  • Adel M. Alwahadneh,
  • Salim Hamadi,
  • Luay Abu-Qatouseh and
  • Salah AbuRuz
  • + 10 authors

Background: There is a scarcity of evidence regarding the real-world effectiveness of coronavirus disease 2019 (COVID-19) vaccines. This was the first study to evaluate the effectiveness of four types of vaccines against asymptomatic and symptomatic...

  • Article
  • Open Access
5 Citations
6,969 Views
13 Pages

Estimating the Total Societal Cost of a Hexavalent Vaccine versus a Pentavalent Vaccine with Hepatitis B in South Korea

  • Serim Min,
  • Sun-Hong Kwon,
  • Yeon-Woo Lee,
  • Jung-Min Lee,
  • Eun Jin Bae and
  • Eui-Kyung Lee

In South Korea, the ready-to-use hexavalent vaccine (against diphtheria, tetanus, pertussis, poliovirus, Haemophilus influenzae type b, and hepatitis B) is not listed despite its facility of no need to reconstitute. It, therefore, has the potential t...

  • Systematic Review
  • Open Access
8 Citations
4,224 Views
11 Pages

ANCA Associated Glomerulonephritis Following SARS-CoV-2 Vaccination: A Case Series and Systematic Review

  • Theerachai Thammathiwat,
  • Athiphat Banjongjit,
  • Kroonpong Iampenkhae,
  • Natavudh Townamchai and
  • Talerngsak Kanjanabuch

Vaccines against SARS-CoV-2 (COVID-19) proved beneficial for COVID-19 disease attenuation and preventing virus spreading. Cumulative reports of the rarity of antineutrophil cytoplasmic autoantibodies (ANCA)-associated vasculitis (AAV) raise concerns...

  • Article
  • Open Access
4 Citations
4,686 Views
18 Pages

Mucosal Vaccination with Live Attenuated Bordetella bronchiseptica Protects against Challenge in Wistar Rats

  • Beatriz Miguelena Chamorro,
  • Karelle De Luca,
  • Gokul Swaminathan,
  • Nicolas Rochereau,
  • Jade Majorel,
  • Hervé Poulet,
  • Blandine Chanut,
  • Lauriane Piney,
  • Egbert Mundt and
  • Stéphane Paul

Bordetella bronchiseptica (Bb) is a Gram-negative bacterium responsible for canine infectious respiratory disease complex (CIRDC). Several vaccines targeting this pathogen are currently licensed for use in dogs, but their mechanism of action and the...

  • Article
  • Open Access
4 Citations
2,201 Views
12 Pages

Determinants of COVID Vaccination Willingness among Health and Non-Health Studies Students: A Cross-Sectional Study

  • Mario Marendić,
  • Diana Aranza,
  • Ivan Aranza,
  • Dario Vrdoljak,
  • Mario Podrug and
  • Mirjana Milić

Students, as a relatively health-informed population group, may still have limitations in health literacy, which is a concern as students take increasing responsibility for their health and make independent health decisions. The aim of this study was...

  • Brief Report
  • Open Access
6 Citations
3,212 Views
9 Pages

Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group

  • Kerstin Aimla,
  • Justyna Dominika Kowalska,
  • Raimonda Matulionyte,
  • Velida Mulabdic,
  • Anna Vassilenko,
  • Natalie Bolokadze,
  • David Jilich,
  • Sergii Antoniak,
  • Cristiana Oprea and
  • Agata Skrzat-Klapaczyńska
  • + 12 authors

(1) Background: Viral hepatitis C (HCV) and viral hepatitis B (HBV) are common co-infections in people living with HIV (PLWH). All PLWH should be vaccinated against HBV and hepatitis A (HAV) and treated for HBV and HCV. We aimed to compare testing, p...

  • Article
  • Open Access
1 Citations
2,895 Views
13 Pages

Real-World Safety and Efficacy Clinical Data of an Improved Allergen-Specific Immunotherapy Product for the Treatment of Bee Venom Allergy

  • Luis Alfredo Gonzalez Guzman,
  • Jose Carlos García Robaina,
  • Javier Barrios Recio,
  • Elena Escudero Arias,
  • Tania Liñares Mata,
  • Raquel Cervera Aznar,
  • Federico De La Roca Pinzón,
  • Lissette del Carmen Miguel Polo,
  • Luis Arenas Villarroel and
  • Francisco Javier Carballada Gonzalez
  • + 4 authors

The aim of this study is to explore the safety and efficacy of bee venom immunotherapy without HSA, in real-life patients. Methods: This is an observational retrospective study developed in seven hospitals in Spain, where patients treated with this i...

  • Article
  • Open Access
5 Citations
2,811 Views
12 Pages

Background: Few data exist on how ofatumumab treatment impacts SARS-CoV-2 booster vaccination response. Methods: KYRIOS is an ongoing prospective open-label multicenter study on the response to initial and booster SARS-CoV-2 mRNA vaccination before o...

  • Article
  • Open Access
3 Citations
3,404 Views
21 Pages

Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV

  • Hiva Azizi,
  • Jason P. Knapp,
  • Yue Li,
  • Alice Berger,
  • Marc-Alexandre Lafrance,
  • Jannie Pedersen,
  • Marc-Antoine de la Vega,
  • Trina Racine,
  • Chil-Yong Kang and
  • Eric J. Arts
  • + 3 authors

Vesicular stomatitis virus (VSV) remains an attractive platform for a potential HIV-1 vaccine but hurdles remain, such as selection of a highly immunogenic HIV-1 Envelope (Env) with a maximal surface expression on recombinant rVSV particles. An HIV-1...

  • Article
  • Open Access
11 Citations
3,299 Views
17 Pages

A Case-Control Study on Factors of HPV Vaccination for Mother and Daughter in China

  • Linyi Chen,
  • Xihong Sun,
  • Jing Luo,
  • Yuanshan Zhang,
  • Yu Ha,
  • Xiaoxia Xu,
  • Liandi Tao,
  • Xuefeng Mu,
  • Shengnan Gao and
  • Fuqiang Cui
  • + 14 authors

(1) Background: To explore the influencing factors of human papillomavirus (HPV) vaccination among mothers and daughters so as to provide evidence and strategies for improving the HPV vaccination rate of 9–18-years-old girls. (2) A questionnair...

  • Article
  • Open Access
5 Citations
3,521 Views
22 Pages

Optimizing the Production of gp145, an HIV-1 Envelope Glycoprotein Vaccine Candidate and Its Encapsulation in Guanosine Microparticles

  • Pearl Akamine,
  • José A. González-Feliciano,
  • Ruth Almodóvar,
  • Gloriner Morell,
  • Javier Rivera,
  • Coral M. Capó-Vélez,
  • Manuel Delgado-Vélez,
  • Luis Prieto-Costas,
  • Bismark Madera and
  • José A. Lasalde-Dominicci
  • + 6 authors

We have developed a pipeline to express, purify, and characterize HIV envelope protein (Env) gp145 from Chinese hamster ovary cells, to accelerate the production of a promising vaccine candidate. First in shake flasks, then in bioreactors, we optimiz...

  • Review
  • Open Access
24 Citations
9,823 Views
28 Pages

Experiences, Enablers, and Challenges in Service Delivery and Integration of COVID-19 Vaccines: A Rapid Systematic Review

  • Sarah Nabia,
  • Chizoba Barbara Wonodi,
  • Alba Vilajeliu,
  • Sabine Sussman,
  • Katharine Olson,
  • Rianna Cooke,
  • Krishna Udayakumar,
  • Claire Twose,
  • Nwamaka Ezeanya and
  • Ann Lindstrand
  • + 1 author

The COVID-19 vaccination is a crucial public health intervention for controlling the spread and severity of the SARS-CoV2 virus. COVID-19 vaccines have been developed in record time, but their deployment has varied across countries, owing to differen...

  • Article
  • Open Access
5 Citations
3,788 Views
18 Pages

COVID-19 Vaccine Perceptions among Ebola-Affected Communities in North Kivu, Democratic Republic of the Congo, 2021

  • Stephanie Chow Garbern,
  • Shiromi M. Perera,
  • Eta Ngole Mbong,
  • Shibani Kulkarni,
  • Monica K. Fleming,
  • Arsene Baleke Ombeni,
  • Rigobert Fraterne Muhayangabo,
  • Dieula Delissaint Tchoualeu,
  • Ruth Kallay and
  • Adam C. Levine
  • + 12 authors

Populations affected by humanitarian crises and emerging infectious disease outbreaks may have unique concerns and experiences that influence their perceptions toward vaccines. In March 2021, we conducted a survey to examine the perceptions toward CO...

  • Article
  • Open Access
1 Citations
2,554 Views
13 Pages

COVID-19 Prevention Behaviours and Vaccine Acceptability, and Their Association with a Behaviour Change Campaign in Somalia: Analysis of a Longitudinal Cohort

  • Andrew Seal,
  • Mohamed Jelle,
  • Mohamed Yusuf Hassan,
  • Dek Abdi Farah,
  • Faith Mueni Musili,
  • Janet Micheni,
  • George Samuel Asol,
  • Meena Bhandari and
  • Balint Nemeth

Somalia experienced its first wave of COVID-19 infections in March 2020 and has experienced fluctuating infection levels since. Longitudinal data on suspected cases of COVID-19, attitudes, and behaviours were collected by telephone interviews of cash...

  • Article
  • Open Access
8 Citations
8,191 Views
14 Pages

Selection Effects and COVID-19 Mortality Risk after Pfizer vs. Moderna Vaccination: Evidence from Linked Mortality and Vaccination Records

  • Vladimir Atanasov,
  • Natalia Barreto,
  • Jeff Whittle,
  • John Meurer,
  • Benjamin W. Weston,
  • Qian (Eric) Luo,
  • Andy Ye Yuan,
  • Lorenzo Franchi,
  • Ruohao Zhang and
  • Bernard Black

Prior research generally finds that the Pfizer-BioNTech (BNT162b2) and Moderna (mRNA1273) COVID-19 vaccines provide similar protection against mortality, sometimes with a Moderna advantage due to slower waning. However, most comparisons do not addres...

  • Conference Report
  • Open Access
10 Citations
6,542 Views
8 Pages

Experimental Medicine for HIV Vaccine Research and Development

  • Holly Prudden,
  • Roger Tatoud,
  • Cathy Slack,
  • Robin Shattock,
  • Pervin Anklesaria,
  • Linda-Gail Bekker and
  • Susan Buchbinder

The development of safe and effective HIV vaccines has been a scientific challenge for more than 40 years. Despite disappointing results from efficacy clinical trials, much has been learnt from years of research and development. In a rapidly evolving...

  • Review
  • Open Access
2 Citations
4,416 Views
15 Pages

Serological Response to SARS-CoV-2 after COVID-19 Vaccination in Lung Cancer Patients: Short Review

  • Ananda M. Rodilla,
  • Sooyun Tavolacci,
  • Jazz Cagan,
  • Tanay Shah,
  • Sandeep Mittan,
  • Philip C. Mack and
  • Fred R. Hirsch

In comparison to the general population, lung cancer patients are more likely to suffer from severe Coronavirus disease (COVID-19) and associated mortality. Considering this increased risk, and in order to prevent symptoms and severe disease, patient...

  • Article
  • Open Access
19 Citations
2,027 Views
11 Pages

For SARS-CoV-2 mutants, the effectiveness of the COVID-19 vaccines is still controversial. In this study, we aimed to investigate the clinical characteristics of Omicron-infected patients who completed primary immunization and booster immunization, r...

  • Article
  • Open Access
6 Citations
3,630 Views
22 Pages

Adolescents’ Opinions on COVID-19 Vaccine Hesitancy: Hints toward Enhancing Pandemic Preparedness in the Future

  • Alessio Muscillo,
  • Gabriele Lombardi,
  • Elena Sestini,
  • Francesca Garbin,
  • Vittoradolfo Tambone,
  • Laura Leondina Campanozzi and
  • Paolo Pin

To understand and assess vaccine reluctance, it is necessary to evaluate people’s perceptions and grasp potential reasons for generic apprehension. In our analysis, we focus on adolescents’ impressions towards anti-vaxxer behavior. The ai...

  • Article
  • Open Access
2,808 Views
17 Pages

Potential of Nucleic Acid Receptor Ligands to Improve Vaccination Efficacy against the Filarial Nematode Litomosoides sigmodontis

  • Johanna F. Scheunemann,
  • Frederic Risch,
  • Julia J. Reichwald,
  • Benjamin Lenz,
  • Anna-Lena Neumann,
  • Stephan Garbe,
  • Stefan J. Frohberger,
  • Marianne Koschel,
  • Jesuthas Ajendra and
  • Marc P. Hübner
  • + 6 authors

More than two-hundred-million people are infected with filariae worldwide. However, there is no vaccine available that confers long-lasting protection against filarial infections. Previous studies indicated that vaccination with irradiated infective...

  • Article
  • Open Access
7 Citations
3,434 Views
13 Pages

A Plant-Derived Maternal Vaccine against Porcine Epidemic Diarrhea Protects Piglets through Maternally Derived Immunity

  • Eun-Ju Sohn,
  • Hyangju Kang,
  • Kyungmin Min,
  • Minhee Park,
  • Ju-Hun Kim,
  • Hwi-Won Seo,
  • Sang-Joon Lee,
  • Heeyeon Kim,
  • Dongseob Tark and
  • Yeonsu Oh
  • + 2 authors

Newborn piglets are susceptible to a highly contagious enteritis caused by the porcine epidemic diarrhea virus (PEDV), associated with high levels of mortality worldwide. There is pressing need for a rapid, safe, and cost-effective vaccine to safegua...

  • Article
  • Open Access
6 Citations
4,719 Views
21 Pages

Acceptance of COVID-19 Vaccines in India: A Systematic Review and Meta-Analysis

  • Gunjan Kumar,
  • Samikshya Jena,
  • Niher Tabassum Snigdha,
  • Sakeenabi Basha,
  • Jayaraj Kodangattil Narayanan and
  • Alexander Maniangat Luke

This systematic review and meta-analysis sought to evaluate the acceptability levels for COVID vaccine(s) in various states in India. Published articles in PubMed/Scopus/Cochrane/DOAJ/the Web of Science that focused on assessing COVID-19 vaccine hesi...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X